LOGO
LOGO

Corporate News

Endava Stock Plunges 30% Despite Revenue Growth In Q3

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Endava plc (DAVA) shares tumbled 29.99 percent to $14.99 on Wednesday after the company reported its fiscal third-quarter 2025 results. Revenue rose 11.7 percent year over year to 194.8 million pounds, up from 174.4 million pounds.

Despite the earnings improvement, investor reaction was negative on the New York Stock Exchange. The stock opened at $18.05 and dropped as low as $14.78 during the session, with a high of $18.17. Trading volume spiked to 2.74 million shares, far above the average of 574,071. Endava now trades at the bottom of its 52-week range of $14.78 to $34.94.

The company swung to a profit of 10.9 million pounds, or 0.18 pounds per share, compared to a loss of 1.7 million pounds, or 0.03 pounds per share, in the prior-year quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.